NCT05756348

Brief Summary

The current study will evaluate the duration of wear and durability of two commercially available SBPs: Medline Marathon® XL (extra long) No Sting Cyanoacrylate Skin Protectant (henceforth referred to as "Marathon®") and 3M™ Cavilon™ Advanced Skin Protectant (henceforth referred to as "Cavilon™").

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 6, 2022

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

October 19, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 22, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 6, 2023

Completed
12 months until next milestone

Results Posted

Study results publicly available

February 20, 2024

Completed
Last Updated

February 20, 2024

Status Verified

August 1, 2023

Enrollment Period

2 months

First QC Date

October 19, 2022

Results QC Date

June 27, 2023

Last Update Submit

February 16, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Duration

    To evaluate the duration of wear of Marathon® and Cavilon™ using the Corneometer® CM (capacitance method) 825 taking measurements of the skin (in Arbitrary Units) with the skin protectant applied at various time points compared to the skin control site without skin protectant at the same time points.

    7 Days - Baseline + 6 visits = 7

  • Durability

    To evaluate the durability of Marathon® and Cavilon™ using the Corneometer® CM 825 taking measurements of the skin (in Arbitrary Units) in the inner elbow location with the skin protectant applied at various time points compared to the skin control site without skin protectant at the same time points.

    7 Days - Baseline + 6 visits = 7

Secondary Outcomes (3)

  • Participant Feedback 2

    1 day

  • Participant Feedback

    2 Days

  • Participant Feedback - Product Preference

    7 Days - Baseline + 6 visits = 7

Study Arms (1)

receives both product

OTHER

all participants receive both products under evaluation.

Device: Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant

Interventions

All participants will receive both device interventions listed above.

receives both product

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals ≥ 18 years of age

You may not qualify if:

  • Individuals have skin conditions that might interfere with Corneometer® measurements, including rash, irritation, sunburn, tattoo, birthmark, any other dermal irregularities on the left or right volar forearm or inner elbow.
  • Individuals have excessive hair on the left or right volar forearm or inner elbow as determined by study personnel.
  • Individuals have a self-reported allergy/sensitivity to ingredients present in either of the SBPs, components of the soap used for bathing, or the exam gloves and non-toxic marker used in the study.
  • Individuals are pregnant.
  • Individuals whose self-reported activities may affect friction on one arm more than the other (eg, sports like tennis or holding a baby where one arm is used more routinely than the other).
  • Individuals who are able to identify the manufacturer of the SBPs included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medline Industries, LP

Northfield, Illinois, 60093, United States

Location

Results Point of Contact

Title
Julie Miller
Organization
Medline Industries, LP

Study Officials

  • Julie Miller

    Medline Industries, LP

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2022

First Posted

March 6, 2023

Study Start

October 6, 2022

Primary Completion

November 22, 2022

Study Completion

November 22, 2022

Last Updated

February 20, 2024

Results First Posted

February 20, 2024

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations